{"entity":{"type":"insider","cik":"0001664690","url":"/insider/0001664690","json_url":"/insider/0001664690.json","name":"Deignan Charles A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2016-06-07","last":"2024-01-19","span_basis":"filed_date"},"name_variants":[{"name":"Deignan Charles A.","source":"filing","n_filings":11,"first_seen":"2016-06-07","last_seen":"2024-01-19"}],"transactions":[{"id":2060060,"accession":"0001209191-24-001959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001959","line_url":"/filing/0001209191-24-001959#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12900.0,"shares_display":"12,900","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":16512.0,"total_display":"16,512.00","total_whole":"16,512","shares_owned_after":384662.0,"shares_owned_after_display":"384,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-19","scope":"insider"},{"id":7948807,"accession":"0001209191-23-004258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004258","line_url":"/filing/0001209191-23-004258#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14030.0,"shares_display":"14,030","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":21045.0,"total_display":"21,045.00","total_whole":"21,045","shares_owned_after":363472.0,"shares_owned_after_display":"363,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":6325713,"accession":"0001209191-22-004194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-004194","line_url":"/filing/0001209191-22-004194#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8833.0,"shares_display":"8,833","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":18460.97,"total_display":"18,460.97","total_whole":"18,461","shares_owned_after":351366.0,"shares_owned_after_display":"351,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-20","scope":"insider"},{"id":4741150,"accession":"0001209191-21-057457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057457","line_url":"/filing/0001209191-21-057457#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":6.41,"price_display":"6.41","price_state":"stated","total_value":17948.0,"total_display":"17,948.00","total_whole":"17,948","shares_owned_after":316449.0,"shares_owned_after_display":"316,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-23","scope":"insider"},{"id":4938503,"accession":"0001209191-21-042803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-042803","line_url":"/filing/0001209191-21-042803#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2938.0,"shares_display":"2,938","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":12839.06,"total_display":"12,839.06","total_whole":"12,839","shares_owned_after":319249.0,"shares_owned_after_display":"319,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":2880694,"accession":"0001209191-20-034062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-034062","line_url":"/filing/0001209191-20-034062#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14992.0,"shares_display":"14,992","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":28184.96,"total_display":"28,184.96","total_whole":"28,185","shares_owned_after":220827.0,"shares_owned_after_display":"220,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-03","scope":"insider"},{"id":8069375,"accession":"0001209191-19-056254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056254","line_url":"/filing/0001209191-19-056254#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":8550.0,"total_display":"8,550.00","total_whole":"8,550","shares_owned_after":203856.0,"shares_owned_after_display":"203,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-13","scope":"insider"},{"id":8343966,"accession":"0001209191-19-019884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-019884","line_url":"/filing/0001209191-19-019884#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":13600.0,"total_display":"13,600.00","total_whole":"13,600","shares_owned_after":76356.0,"shares_owned_after_display":"76,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-18","scope":"insider"},{"id":6075977,"accession":"0001209191-18-021647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021647","line_url":"/filing/0001209191-18-021647#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":11.79,"price_display":"11.79","price_state":"stated","total_value":5895.0,"total_display":"5,895.00","total_whole":"5,895","shares_owned_after":66356.0,"shares_owned_after_display":"66,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-26","scope":"insider"},{"id":4084355,"accession":"0001209191-17-048783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-048783","line_url":"/filing/0001209191-17-048783#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.065,"price_display":"7.06","price_state":"stated","total_value":7065.0,"total_display":"7,065.00","total_whole":"7,065","shares_owned_after":65309.0,"shares_owned_after_display":"65,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-14","scope":"insider"},{"id":2997236,"accession":"0001209191-16-126266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-126266","line_url":"/filing/0001209191-16-126266#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664690","owner_name":"Deignan Charles A.","owner_display_name":"Deignan Charles A.","owner_url":"/insider/0001664690","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2.0,"shares_display":"2","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":14.0,"total_display":"14.00","total_whole":"14","shares_owned_after":62759.0,"shares_owned_after_display":"62,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001539029","name":"Clearside Biomedical, Inc.","url":"/issuer/0001539029","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2016-06-07","last_seen":"2024-01-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001664690","retrieved_at":"2026-08-25T08:36:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}